1BELTOWSKI J, JAMROZ-WISNIEWSKA A, WIDOMSKA S. Adiponectin and its role in cardiovascular diseases [ J ]. Cardiovasc Hematol Disord Drug Targets, 2008,8 ( 1 ) : 7 - 46.
2POLAK J,KOVACOVA Z,HOLST C,et al. Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women : the NUGENOB study [ J ] . Eur J Endocrinol, 2008,158(4) :533 -541.
3WANG Jing, LI Huai xing,et al. Adiponectin and metabolic syndromein middle-aged and elderly Chinese [ J ]. Obesity, 2008,16:172 - 178.
4SHIBATA R, OUCHI N, ITO M, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart [J]. Nat Med,2004 ,10:1384 -1389.
5YAMAUCHI T, KAMON J, ITO Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects[J]. Nature,2003, 423:762 -769.
6CHINETTI G Z, FRUCHART J C, STAELS B. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR [ J ]. Biochem Biophys Res Commun ,2004,314 : 151 - 158.
7HUG C, WANG J, AHMAD N S, et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin[ J ]. Proc Natl Acad Sci USA, 2004, 101 : 10308 - 10313.
8ARITA Y, KIHARA S, OUCHI N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem [ J ]. Biophys Res Commun, 1999,257 : 79 -83.
9MOTOSHIMA H, WU X, SINHA M K, et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone [ J ]. J Clin Endocrinol Metab, 2002,87 : 5662 - 5667.
10NISHIDA K, OKADA Y, NAWATA M,et al. Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody[ J]. J Endocr ,2008 ,55 (1) : 213 -216.
